The largest database of trusted experimental protocols

Golden gate snp genotyping arrays

Manufactured by Illumina

The Golden Gate SNP Genotyping Arrays are a high-throughput genotyping platform developed by Illumina. The arrays enable the analysis of hundreds to thousands of single nucleotide polymorphisms (SNPs) in a single reaction, providing a efficient and cost-effective solution for genetic analysis and research applications.

Automatically generated - may contain errors

4 protocols using golden gate snp genotyping arrays

1

Genomic DNA Extraction and SNP Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
We collected 10 ml ETDA-anticoagulated venous blood, and separated the plasma and white blood cell layer, and stored the white blood cells in a cryotube at -80° C Celsius refrigerator for DNA extraction. Genomic DNA was extracted using QIAGEN DNA Extraction Kit (QIAGEN Inc.) [37 (link)]. The Illumina Golden Gate SNP Genotyping Arrays was used to genotype 192 SNPs in stage I. The TaqMan platform was taken to genotype 8 SNPs associated with breast cancer prognosis in stage II. We used a 5-μl reaction mixture system with 20 ng of genomic DNA, 2.5 μl of 2×TaqMan Genotyping Master Mix, 0.1 μl of 40×probe and 1.9μl of double distilled water. The PCR reaction conditions were 95° C for 10 minutes, followed by 50 cycles of 92° C for 30 seconds, and 60° C for 1 minutes. We amplified using the 384-well reaction plates and performed genotype analysis using SDS 2.4 software (Applied Biosystems, Foster City, CA, USA). In order to ensure the accuracy and reliability of the experimental results, approximately 5% of the samples were randomly selected for retesting.
+ Open protocol
+ Expand
2

Robust SNP Genotyping using Illumina and TaqMan

Check if the same lab product or an alternative is used in the 5 most similar protocols
In stage I, SNP genotyping was conducted using Illumina Golden Gate SNP Genotyping Arrays according to the manufacturer’s instructions. Only plates with a consistent high call rate in the initial calling were used. If the call rate was <80%, we repeat the experiment. In stage II, genotyping were performed using the TaqMan platform in 384-well plates and read with the Sequence Detection Software on an ABI Prism 7900 instrument according to the manufacturer’s instructions (Applied Biosystems, Foster City, CA). Primers and probes were supplied by Applied Biosystems, the PCR conditions used were as follows: 50°C for 2 minutes, 95°C for 10 minutes, and 60°C for 1 minute for 40 cycles. After 2 rounds of genotyping, the success rate for genotyping was 99%, and 5% of the samples were selected for replication, the results were 100% concordant.
+ Open protocol
+ Expand
3

Breast Cancer Risk SNP Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from peripheral blood using QIAGEN DNA Extraction Kit (QIAGEN Inc.) [15] . The Illumina Golden Gate SNP Genotyping Arrays was used to genotype 192 SNPs in stage I. The TaqMan platform was taken to genotype 8 SNPs associated with breast cancer prognosis in stage II. We used a 5-μl reaction mixture system with 20 ng of genomic DNA, 2.5 μl of 2×TaqMan Genotyping Master Mix, 0.1 μl of 40×probe and 1.9μl of double distilled water. The PCR reaction conditions were 95℃ for 10 minutes, followed by 50 cycles of 92℃ for 30 seconds, and 60℃ for 1 minutes. We ampli ed using the 384-well reaction plates and performed genotype analysis using SDS 2.4 software (Applied Biosystems, Foster City, CA, USA). In order to ensure the accuracy and reliability of the experimental results, approximately 5% of the samples were randomly selected for retesting.
+ Open protocol
+ Expand
4

Breast Cancer Risk SNP Genotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genomic DNA was extracted from peripheral blood using QIAGEN DNA Extraction Kit (QIAGEN Inc.) [15] . The Illumina Golden Gate SNP Genotyping Arrays was used to genotype 192 SNPs in stage I. The TaqMan platform was taken to genotype 8 SNPs associated with breast cancer prognosis in stage II. We used a 5-μl reaction mixture system with 20 ng of genomic DNA, 2.5 μl of 2×TaqMan Genotyping Master Mix, 0.1 μl of 40×probe and 1.9μl of double distilled water. The PCR reaction conditions were 95℃ for 10 minutes, followed by 50 cycles of 92℃ for 30 seconds, and 60℃ for 1 minutes. We ampli ed using the 384-well reaction plates and performed genotype analysis using SDS 2.4 software (Applied Biosystems, Foster City, CA, USA). In order to ensure the accuracy and reliability of the experimental results, approximately 5% of the samples were randomly selected for retesting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!